Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Eisai wins US approval for chemotherapy side effects drug

FDA backs Akynzeo to treat nausea and vomiting

Pharma deals during September 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for September 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Go with the flow: lab-on-a-chip devices

Microfluidic, or lab-on-a-chip, devices have been used by pharma scientists for years but are now threatening to break into mainstream use

- PMLiVE

Endo to acquire Auxilium for $2.6bn

Puts end to takeover deal for QLT

- PMLiVE

Amgen leukaemia drug gets FDA priority review

Adds to breakthrough status for blinatumomab

Novartis building

Novartis’ secukinumab has ‘consistent’ activity in psoriasis

Reinforces data that suggests drug is more effective than Amgen’s Enbrel

- PMLiVE

EMG appoints Merck and Boehringer directors as new officers

David Garmon-Jones is new chair and Zinta Krumins is vice chair

- PMLiVE

NHS England invests £120m to tackle mental health

Standards to put mental illness on equal footing with physical health issues

- PMLiVE

Tonic names Mary Smiddy as global CEO

And Tamsin Tierney is promoted to managing director for Europe

- PMLiVE

Takeda opens new UK office in High Wycombe

Hopes move to larger premises will help expand business

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links